相关实验视频
Updated: May 28, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.6K
产后血糖控制与胰岛素输注与旋转液体:一个随机对照试验
Maranda Sullivan1, Kajal Angras1, Victoria Boyd1
1Department of Maternal-Fetal Medicine, Geisinger Medical Center, Danville, Pennsylvania.
American journal of perinatology
|February 10, 2025
概括
轮流静脉输液和胰岛素输注显示出对孕产妇产后血糖控制的可比结果,新生儿在出生后两小时内血糖水平没有显著差异.
科学领域:
- 产科和妇科 产科和妇科
- 新生儿医学 新生儿医学
- 内分泌学 在内分泌学.
背景情况:
- 有效的产后血糖控制对于管理患有糖尿病 (II型糖尿病或A2GDM) 的孕妇至关重要.
- 目前的管理策略旨在保持稳定的母体血糖,以优化新生儿的结果.
- 评估在分娩期间血糖控制的替代方法是必不可少的.
研究的目的:
- 为了比较循环静脉注射 (IV) 液体与持续胰岛素输注的疗效,用于孕产妇产后血糖控制.
- 评估这些干预措施对新生儿在出生后2小时内血糖水平的影响.
主要方法:
- 一项随机对照试验,涉及114名II型DM或A2GDM的参与者.
- 轮流输液流体与持续胰岛素输液用于产妇内血糖管理的比较.
- 分析新生儿2小时和24小时血糖,Apgar分数和综合新生儿结局;母亲的结局包括低血糖和分娩方式.
主要成果:
- 在出生后2小时内,新生儿血糖水平在循环静脉输液组 (54.5 mg/dL ITT) 和胰岛素输液组 (59.0 mg/dL ITT) 之间没有显著差异.
- 观察到可比的孕产妇产后血糖水平 (98.5 mg/dL vs. 96.3 mg/dL) 和类似的新生儿低血糖率 (11.8% vs. 15.6%).
- 在两种治疗手臂之间,在二次新生儿或孕产妇结局中没有发现显著差异.
结论:
- 轮流静脉注射液与连续胰岛素输注一样有效,用于糖尿病孕妇的产后血糖控制.
- 这两种方法的结果是可比的新生儿血糖水平,并没有显著改变关键的新生儿或母亲的结果.
- 目前,基于这一比较,对于产妇在分娩期间的血糖控制没有明确的最佳选择.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
140
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
140
Insulin Formulations: Types and Delivery
162
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
162

